With this two-pronged strategy, which examined transgenic zebrafish embryos overexpressing mutated IDS, we aimed to quickly evaluate which point mutations were critical to the occurrence of MPS II. The gene discussed is IDS; the disease is mucopolysaccharidosis type 2.